BILIFALK

Serial Number 86025219
606

Registration Progress

Application Filed
Jul 31, 2013
Under Examination
Apr 1, 2014
Approved for Publication
Feb 4, 2014
Published for Opposition
Feb 4, 2014
Registered

Trademark Image

BILIFALK

Basic Information

Serial Number
86025219
Filing Date
July 31, 2013
Published for Opposition
February 4, 2014
Abandonment Date
May 8, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 8, 2017
Classes
005

Rights Holder

Dr. Falk Pharma GmbH

99
Address
Leinenweberstrasse 5
Freiburg D-79108
DE

Ownership History

Dr. Falk Pharma GmbH

Original Applicant
99
Freiburg DE

Dr. Falk Pharma GmbH

Owner at Publication
99
Freiburg DE

Legal Representation

Attorney
David G. Boutell

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
May 8, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 8, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Aug 27, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 26, 2016 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 17, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 17, 2016 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 2, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 1, 2016 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 18, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 18, 2016 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 18, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 17, 2015 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 5, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 5, 2015 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 12, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 11, 2015 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 10, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 22, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 22, 2015 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 2, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2014 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 30, 2014 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 1, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 4, 2014 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 4, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 15, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 30, 2013 ALIE A ASSIGNED TO LIE Loading...
Dec 30, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Dec 24, 2013 ALIE A ASSIGNED TO LIE Loading...
Dec 2, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 23, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 22, 2013 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 22, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 14, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 14, 2013 CNSL R SUSPENSION LETTER WRITTEN Loading...
Nov 14, 2013 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Nov 14, 2013 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 8, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 3, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the dissolution of cholesterol gallstones in the gallbladder, for the treatment of biliary reflux gastritis, of cholestatic liver diseases and of cystic fibrosis associated liver disease
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005